Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Kayenat S Aryeh"'
Autor:
Yin Zhang, Julie M Huynh, Guan-Sheng Liu, Richard Ballweg, Kayenat S Aryeh, Andrew L Paek, Tongli Zhang
Publikováno v:
PLoS Computational Biology, Vol 15, Iss 9, p e1007158 (2019)
Chemotherapy resistance is a major challenge to the effective treatment of cancer. Thus, a systematic pipeline for the efficient identification of effective combination treatments could bring huge biomedical benefit. In order to facilitate rational d
Externí odkaz:
https://doaj.org/article/f501b1749c324b698edad8e4e09907c9
Publikováno v:
Cancer Research. 80:2471-2471
Epidermal Growth Factor Receptor (EGFR) tyrosine kinase inhibitors (TKIs) are a first line treatment for patients with advanced non-small cell lung cancer (NSCLC) who have specific hyperactive mutations in EGFR. Though patients have seen improvements
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::75724dc2a52b901ad7bf34deab89a9b2
https://doi.org/10.1158/1538-7445.am2020-2471
https://doi.org/10.1158/1538-7445.am2020-2471
Autor:
Andrew L. Paek, Guan-Sheng Liu, Yin Zhang, Tongli Zhang, Richard Ballweg, Kayenat S. Aryeh, Julie M. Huynh
Publikováno v:
PLoS Computational Biology, Vol 15, Iss 9, p e1007158 (2019)
PLoS Computational Biology
PLoS Computational Biology
Chemotherapy resistance is a major challenge to the effective treatment of cancer. Thus, a systematic pipeline for the efficient identification of effective combination treatments could bring huge biomedical benefit. In order to facilitate rational d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00c8c657f2c46b40f3256c1ef0ff2843
https://doi.org/10.1371/journal.pcbi.1007158
https://doi.org/10.1371/journal.pcbi.1007158